-
effectivehealthcare.ahrq.gov/sites/default/files/tech-brief-37-opiod-use-adults-comments.pdf
November 03, 2020 - This represents a
fundamental and ethically unacceptable failure of
public transparency, and should
-
digital.ahrq.gov/sites/default/files/docs/citation/shareable-cds-efficiencies-final-report.pdf
December 01, 2019 - • Trust and transparency are important aspects of sharing CDS resources.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
May 01, 2022 - Transparency and stakeholder input are essential to the Effective Health Care Program.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
March 01, 2022 - Transparency and stakeholder input are essential to the Effective Health Care Program.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_disposition-comments.pdf
March 01, 2012 - Disposition of Comments for Venous Thromboembolism Prophylaxis in Orthopedic Surgery
Source: http://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and-
reports/?pageaction=displayproduct&productid=992
Published Online: March 2012
Comparative Effectiveness Research Review Dispositio…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_disposition-comments.pdf
November 27, 2012 - Dispostion of Comments Report for Screening for Hepatitis C Virus Infection in Adults
Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-
reports/?pageaction=displayproduct&productID=1283
Published Online: November 27, 2012
Comparative Effectiveness Research Review Disposition of Comm…
-
www.ahrq.gov/sites/default/files/wysiwyg/ecareplan/reports/ecare-plan-for-mcc-v2.pdf
January 01, 2025 - Implementation of an Electronic Care Plan for People with Multiple Chronic Conditions, Version 2: Evaluation Report
January 2025
Implementation of an Electronic
Care Plan for People with Multiple
Chronic Conditions, Version 2
Evaluation Report
Prepared for
Agency for Healthcare Research and Quality
…
-
effectivehealthcare.ahrq.gov/sites/default/files/back-pain-treatment_disposition-comments.pdf
February 29, 2016 - Disposition of comments for CER 169 Low Back Pain
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Noninvasive Treatments for Low Back Pain
Draft review available for public comment from April 27, 2015 to May 18, 2015.
Research Review Citation: Chou R, Deyo R, Friedly J, Sk…
-
digital.ahrq.gov/sites/default/files/docs/page/sustainability-partnerships-and-teamwork-in-health-it-implementation.pdf
December 01, 2012 - Executive Summary
Sustainability,
Partnership, and
Teamwork in
Health IT
Implementation
Findings From the Transforming
Healthcare Quality Through
IT Grants
Agency for Healthcare Research and Quality
Advancing Excellence in Health Care www.ahrq.gov
Final RepoRt
Sustainability, Partnerships, and Team…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse_disposition-comments.pdf
July 10, 2012 - Disposition of Comments Report for Screening, Behavioral Counseling, and Referral in Primary Care To Reduce Alcohol Misuse
http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productID=1134
Published Online: July 10, 2012
Comparative Effectiveness Research Re…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-adhd-prescription-rapid-research.pdf
July 01, 2025 - Rapid Evidence Product: Misuse of ADHD Prescription Stimulants in Adults
Rapid Evidence Product
June 2025
Misuse of ADHD Prescription
Stimulants in Adults
Background and Purpose
The U.S. Food and Drug Administration (FDA) commissioned a rapid review, through the
Agency for Healthcare Research an…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
March 01, 2024 - Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments
Rapid Evidence Product
Adverse Events Associated With
COVID-19 Pharmaceutical Treatments
Background and Purpose
The purpose of this rapid review is to determine if COVID treatments authorized for
emergency use…